CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- 4 Open-market buy Director bought 7,000 shares at $2.85 ($19,950)
- 4 Open-market buy President & CEO bought 6,000 shares at $2.90 ($17,400)
- 4 Open-market buy Director bought 15,000 shares at $2.75 ($41,247)
- 4 Open-market buy Director bought 15,000 shares at $2.82 ($42,267)
- 4 Open-market buy Director bought 5,000 shares at $3.00 ($15,003)
- 4/A Open-market buy 10% owner bought 85,461 shares at $3.04 ($259,468)
- 4 Open-market buy 10% owner bought 85,461 shares at $4.00 ($341,844)
- 4 Open-market buy 10% owner bought 20,411 shares at $4.00 ($81,644)
- 4 Exercise or conversion Director acquired 1,028 shares (option exercise)
- 4 Open-market buy 10% owner bought 26,408 shares at an average $3.84 ($101,518)
- 4 Open-market buy 10% owner bought 358,698 shares at an average $3.81 ($1,366,146)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion SVP Bus. & Corp. Development acquired 2,057 shares (option exercise)
Page 13 of 19 · 370 filings